Examples of FDA Acceptance in a sentence
Zogenix Announces U.S. FDA Acceptance for Priority Review of Supplemental New Drug Application for FINTEPLA® (Fenfluramine) for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS).
USL shall be responsible for diligently compiling the Product NDA in accordance with the Development Plan, and for having it filed with the FDA within five (5) months after USL’s receipt of all data, information and documents (including without limitation, all analyses and re-analyses) necessary or beneficial to prepare such filing, and for obtaining FDA Acceptance of the Product NDA.
Finally, FDA promotes the advancement of regulatory science by authoring FDA and international guidances, conducting and 5 For more information on the use of information relating to foreign clinical trials in INDs and applications for marketing approval submitted to FDA, see the guidance for industry and FDA staff FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND: Frequently Asked Questions.
Antares issued a press release entitled “Antares Pharma Announces FDA Acceptance of New Drug Application for QuickShot Testosterone.” In the press release, the Company stated, in part: The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of October 20, 2017, ten months from the official NDA submission.
USL shall pay to Orion a first milestone payment of US Dollars [***] (the “First Milestone Payment”) for previously completed research, formulation and clinical development, payable within thirty (30) days after the later of (a) USL’s receipt of notification of FDA Acceptance of the Product NDA, accompanied by a copy of such FDA Acceptance, if any, and (b) USL’s receipt of Orion’s invoice for such First Milestone Payment.
Finally, the estimated size of the patient population likely to use Tyvaso DPI includes not just PAH and PH-ILD patients, but also patients with other forms of PH categorized as WHO 27 UTC Press Release, United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application for Priority Review (June 16, 2021) (Exhibit 3).
Spero issued a press release entitled “Spero Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis.” The press release stated, in relevant part: Spero [.
USL shall pay to Orion a first milestone payment of US Dollars five hundred thousand ($500,000) (the “First Milestone Payment”) for previously completed research, formulation and clinical development, payable within thirty (30) days after the later of (a) USL’s receipt of notification of FDA Acceptance of the Product NDA, accompanied by a copy of such FDA Acceptance, if any, and (b) USL’s receipt of Orion’s invoice for such First Milestone Payment.
SEEKING ALPHA, LANNETT (LCI) Q1 2019 RESULTS - EARNINGS CALL TRANSCRIPT at 3 (Nov.7, 2018) [Exhibit 4]; see also Press Release, Lannett Co., Lannett Announces FDA Acceptance of 505(b)(2) New Drug Application for Cocaine Hydrochloride Topical Solution, a Proprietary Anesthetic Product (Dec.
VIVUS Reports 2006 Fourth Quarter and Full-Year Financial ResultsPositive Phase 2 Data for Qnexa and FDA Acceptance of EvaMist NDA Submission Lead 2006 HighlightsMOUNTAIN VIEW, Calif., March 2, 2007 — VIVUS, Inc.